首页|疏肝化痰散结方与紫杉醇抗乳腺癌MCF-7/PTX细胞的协同增效作用及机制研究

疏肝化痰散结方与紫杉醇抗乳腺癌MCF-7/PTX细胞的协同增效作用及机制研究

扫码查看
目的 探讨疏肝化痰散结方(SHSF)与紫杉醇抗乳腺癌MCF-7/PTX细胞的协同增效作用及机制.方法 采用低浓度加量持续诱导法建立乳腺癌PTX耐药细胞株MCF-7/PTX,MTT法检测不同浓度PTX对MCF-7和MCF-7/PTX细胞及SHSF含药血清对MCF-7/PTX细胞增殖活性的影响,并根据IC50值计算耐药指数(RI)和逆转倍数.将MCF-7/PTX细胞分为空白对照组、PTX组(45 nmol·L-1 PTX)、SHSF组(7.5%SHSF含药血清)和PTX+SHSF组(45 nmol·L-1 PTX+7.5%SHSF含药血清),药物作用24 h,流式细胞术检测各组细胞凋亡水平;Western blot检测各组细胞中凋亡蛋白Bax、Bcl-2和Akt/mTOR通路相关蛋白p-Akt(ser473)、Akt、p-mTOR(Ser2448)、mTOR等蛋白表达水平.结果 成功建立乳腺癌PTX耐药细胞株MCF-7/PTX,RI值为6.70.随着SHSF含药血清的浓度增加,MCF-7/PTX细胞增殖活性呈浓度依赖性降低;7.5%SHSF含药血清对MCF-7/PTX细胞的耐药性逆转倍数为3.48.与空白对照组比较,PTX组和SHSF组MCF-7/PTX细胞凋亡水平显著增加(P<0.01),Bax蛋白表达水平显著上调(P<0.01),Bcl-2、p-Akt/Akt和p-mTOR/mTOR蛋白表达水平显著下调(P<0.05);与PTX组相比,PTX+SHSF组细胞凋亡水平显著增加(P<0.01),Bax蛋白表达水平显著上调(P<0.01),Bcl-2、p-Akt和p-mTOR蛋白表达水平显著下调(P<0.01).结论 疏肝化痰散结方通过抑制Akt/mTOR通路促进细胞凋亡,从而发挥与紫杉醇抗乳腺癌MCF-7/PTX细胞的协同增效作用.
Synergistic Effect and Mechanism of Shugan Huatan Sanjie Recipe and Paclitaxel Against Breast Cancer MCF-7/PTX Cells
Objective To investigate the synergistic effect of Shugan Huatan Sanjie prescription(SHSF)and paclitaxel on MCF-7/PTX cells of breast cancer and its mechanism.Methods The PTX-resistant breast cancer cell line MCF-7/PTX was established by continuous induction of low concentration.The effects of different concentrations of PTX on MCF-7 and MCF-7/PTX cells.Then the proliferation of MCF-7/PTX cells by SHSF containing serum were detected by MTT assay,and the drug resistance index(RI)and reversion times were calculated according to the IC50 value.MCF-7/PTX cells were divided into blank control group,PTX group(45 nmol·L-1 PTX),SHSF group(7.5%SHSF drug-containing serum)and PTX+SHSF group(45 nmol·L-1 PTX+7.5%SHSF drug-containing serum).The cells were treated with drugs for 24 h.The apoptosis level of each group was detected by flow cytometry.The expression levels of apoptotic proteins Bax,Bcl-2,p-Akt(ser473),Akt,p-mTOR(Ser2448)and mTOR were detected by Western blot.Results The PTX-resistant cell line MCF-7/PTX was established successfully,and the RI value was 6.70.The proliferative activity of MCF-7/PTX cells decreased in a concentration-dependent manner with the increase of SHSF drug-containing serum concentration.And the resistance reversal ratio of 7.5%SHSF serum to MCF-7/PTX cells was 3.48.Compared with blank control group,the apoptosis levels of MCF-7/PTX cells in PTX group and SHSF group were significantly increased(P<0.01),the protein expression level of Bax was significantly up-regulated(P<0.01),and the protein expression levels of Bcl-2,p-Akt/Akt and p-mTOR/mTOR were significantly down-regulated(P<0.05);Compared with PTX group,the apoptosis level in PTX+SHSF group was significantly increased(P<0.01),the expression level of Bax protein was significantly up-regulated(P<0.01),and the expression levels of Bcl-2,p-Akt and p-mTOR protein were significantly down-regulated(P<0.01).Conclusion Shugan Huatan Sanjie Recipe promotes apoptosis by inhibiting Akt/mTOR pathway,and thus plays a synergistic effect with paclitaxel on MCF-7/PTX cells of breast cancer.

Shugan Huatan powderBreast cancerPaclitaxel resistanceCell apoptosisAkt/mTOR pathway

张立柱、韩长辉、范焕芳、张洋

展开 >

河北省中医院 石家庄 050011

南宫市人民医院 邢台 055750

疏肝化痰散 乳腺癌 紫杉醇耐药 细胞凋亡 Akt/mTOR通路

2024

世界科学技术-中医药现代化
中科院科技政策与管理科学研究所,中国高技术产业发展促进会

世界科学技术-中医药现代化

CSTPCD北大核心
影响因子:1.175
ISSN:1674-3849
年,卷(期):2024.26(9)